Cargando…
Arsenic trioxide targets Hsp60, triggering degradation of p53 and survivin
The mechanisms of action of arsenic trioxide (ATO), a clinically used drug for the treatment of acute promyelocytic leukemia (APL), have been actively studied mainly through characterization of individual putative protein targets. There appear to be no studies at a system level. Herein, we integrate...
Autores principales: | Hu, Xuqiao, Li, Hongyan, Ip, Tiffany Ka-Yan, Cheung, Yam Fung, Koohi-Moghadam, Mohamad, Wang, Haibo, Yang, Xinming, Tritton, Daniel N., Wang, Yuchuan, Wang, Yi, Wang, Runming, Ng, Kwan-Ming, Naranmandura, Hua, Tse, Eric Wai-Choi, Sun, Hongzhe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372542/ https://www.ncbi.nlm.nih.gov/pubmed/34476069 http://dx.doi.org/10.1039/d1sc03119h |
Ejemplares similares
-
Deciphering molecular mechanism of silver by integrated omic approaches enables enhancing its antimicrobial efficacy in E. coli
por: Wang, Haibo, et al.
Publicado: (2019) -
Tetramethylpyrazine potentiates arsenic trioxide activity against HL-60 cell lines
por: Wu, Yuni, et al.
Publicado: (2012) -
Metallochaperone UreG serves as a new target for design of urease inhibitor: A novel strategy for development of antimicrobials
por: Yang, Xinming, et al.
Publicado: (2018) -
Mifepristone inhibits hepatoma growth by enhancing the GR-HSP60-survivin interaction to facilitate survivin degradation
por: Huang, Ya-Hui, et al.
Publicado: (2023) -
Re-sensitization of mcr carrying multidrug resistant bacteria to colistin by silver
por: Zhang, Qi, et al.
Publicado: (2022)